Pharmakokinetics of Erythromycin

Bass J. W. Steele R. W. Wiebe R. A. Dierdorff E. O. (1971). Erythromycin concentrations in middle ear exudates. Pediatrics, 48. 417–22.

Bennetts F. E. Jackson D. (1977). Absorption of erythromycin. (Personal communication.).

Chun A. H. C Seitz J. A. (1977). Pharmacokinetics and biological availability of erythromycin, Infections.

Coyne T. C. Shum S. Chun A. Shirkey H. C. Bioavailability of erythromycin ethylsuccinate in pediatric patients, submitted for publication in Clin. Pharmacol. Ther..

Dette G. Maassen W. Wadoud A. (1977). Erythromycin concentrations in pulmonary and bronchial tissue - effect of bromhexine on these concentrations. (Personal communication.).

Garrod L. P. Lambert H. P. O'Grady F. (1973). Antibiotic and Chemotherapy, 4th edn. Churchill Livingstone, Edinburgh and London, p. 173.

Griffith R. S. Black H. R. (1970). Erythromycin. Med. Clin. North America, 54, 1199.

Knothe H. (1976). Tabellarium der Chemotherapie. Aesopus Verlag Lugano, München.

Kunin C. M. (1967). A guide to use of antibiotics in patients with renal disease. Ann. Intern. Med., 67, 151.

Nelson E. (1962). Physicochemical factors influencing the absorption of erythromycin and its esters. Chem. Pharm. Bull, 10, 1099–101.

Parsons R. L. Paddock M. Hossack A. (1977). Particular aspects of the pharmakokinetics of erythromycin, Infections.

Philipson A. Sabath L. D. Charles D. (1973). Transplacental passage of erythromycin and clindamycin. New Engl. J. Med., 288, 1219.

Simon C Sommerwerck D. (1977). Sputum levels of erythromycin after single and repeated oral administration in adult patients with bronchitis. (Personal communication.).

Stella V. (1975). Prodrugs: An overview and definition in Higuchi T. Stella V. , eds. Prodrugs as novel delivery systems, Washington, D.C. American Chemical Society, pp. 31–2.

Sundberg L. Ernstson S. (1972). Penetration of erythromycin into middle ear secretion. (Personal communication.).

Tardrew P. L. Mao J. C. H. Kenney D. (1969). Antibacterial activity of 2′esters of erythromycin. Applied Microbiology, 18, 159–65.

Wiegand R. G. Chun A. H. C. (1972). Serum protein binding of erythromycin and erythromycin 2′-propionate ester. J. Pharm. Sci, 61, 425–8.